Ph: 207.396.6433 Fx: 207.396.6436
51 US Route 1 Suite H Scarborough, ME 04074
MetabolicLeader Logo

Metabolic Leader
We specialize in the diagnosis, treatment, and prevention of metabolic disorders of the endocrine system. Opened on November 15, 2010 by Dr. Stephan Babirak to provide the highest quality patient – focused healthcare in the southern Maine region.

LipidologyEndocrinologyApheresisDiabetesEducationResearch

We are now located at
51 US Route 1, Suite H Scarborough, ME 04074

Our Hours

Monday - Thursday
Office Hours:
8:00am – 4:00pm
Phone Hours:
9:00am – 4:00pm
Closed for lunch:
12:00 – 1:00pm
Closed on Friday

Healthy Food, Healthy You!

Eat healthy & get fit with these helpful tips.

APHERESIS Apheresis Video

View our video promoting a higher quality of life through Apheresis.

Are you at Risk for Diabetes?

To Buy Hydroxychloroquine Online Visit Our Pharmacy ↓




Hydroxychloroquine and Autoimmune Disorders: a Promising Treatment Option?

Hydroxychloroquine, a well-known anti-malarial drug, has gained attention in recent years for its potential role in the treatment of autoimmune disorders. This medication has been used for decades to manage conditions such as lupus and rheumatoid arthritis, but its overall mechanisms of action are still not fully understood. Hydroxychloroquine exhibits immunomodulatory properties by reducing the activity of certain immune cells and inhibiting the production of inflammatory substances. It acts by interfering with the function of lysosomes within cells, which are responsible for breaking down waste materials and regulating cellular processes. Studies have suggested that hydroxychloroquine can alleviate symptoms and prevent disease flares in patients with various autoimmune disorders. Furthermore, this drug has shown promising effects in reducing the risk of severe complications in COVID-19 patients. Further research is necessary to explore the full potential of hydroxychloroquine and unlock its power in treating autoimmune disorders.



Revolutionizing Autoimmune Treatment



Hydroxychloroquine has emerged as a potential game-changer in the field of autoimmune treatment. This drug, originally used to treat malaria, has shown promising results in managing various autoimmune disorders. It works by modulating the immune system, reducing inflammation, and suppressing the hyperactive response often seen in these conditions. By targeting specific pathways involved in autoimmune processes, hydroxychloroquine not only alleviates symptoms but also helps prevent disease progression. Its versatility extends beyond the treatment of individual disorders, with studies suggesting its efficacy in combination therapies. The positive impact of hydroxychloroquine on autoimmune treatment has given renewed hope to patients and healthcare professionals alike. While its full potential is yet to be uncovered, the early evidence suggests that hydroxychloroquine could revolutionize the way we approach autoimmune disorders.



Unleashing the Potential Within



Unleashing the Potential WithinHydroxychloroquine, a medication commonly used to treat malaria and certain autoimmune diseases, has shown great promise in revolutionizing autoimmune treatment. Its unique mechanism of action targets the immune system, reducing inflammation and improving symptoms in patients with autoimmune disorders. By modulating immune responses and inhibiting the production of inflammatory molecules, hydroxychloroquine unleashes the potential within the body to regain control over the immune system. This promising treatment option offers hope to those suffering from conditions such as rheumatoid arthritis, lupus, and Sjögren's syndrome. While further research and clinical trials are needed to fully understand the extent of hydroxychloroquine's benefits, its efficacy in managing autoimmune disorders cannot be understated. Despite some skepticism surrounding its use, the growing body of evidence supports the potential of hydroxychloroquine in transforming the lives of individuals with autoimmune diseases.



A Glimpse of Hope



Hydroxychloroquine has emerged as a potential treatment option for autoimmune disorders. Recent studies and clinical trials have shown positive results in utilizing hydroxychloroquine to manage and alleviate symptoms associated with various autoimmune conditions. This drug, primarily used for treating malaria, has demonstrated its ability to modulate the immune system and reduce inflammation, which are key factors in autoimmune diseases. By interfering with certain pathways and suppressing the overactive immune response, hydroxychloroquine offers hope for patients suffering from conditions such as rheumatoid arthritis, lupus, and Sjögren's syndrome. The drug has shown promising outcomes in terms of reducing disease activity, improving quality of life, and minimizing the need for other immunosuppressive medications. While further research is needed to better understand the mechanisms and long-term effects, hydroxychloroquine's potential as a treatment option brings a glimmer of hope to individuals battling autoimmune disorders.



Debunking the Skepticism



Hydroxychloroquine has been a subject of skepticism in recent times, especially in relation to its potential for treating autoimmune disorders. However, a closer look at the available scientific evidence reveals a different story. Studies have shown that hydroxychloroquine possesses unique immunomodulatory effects, making it a promising treatment option for various autoimmune conditions. Despite the controversies and doubts surrounding its efficacy, numerous patients have experienced significant improvements in their symptoms after receiving hydroxychloroquine therapy. Ongoing research and clinical trials continue to explore the full potential of this drug, shedding light on its mechanisms of action and refining its usage in autoimmune disorders. While skepticism remains, the growing body of evidence suggests that hydroxychloroquine could play a crucial role in revolutionizing autoimmune treatment and providing hope for patients who have long struggled with these debilitating conditions.



Overcoming Autoimmune Challenges



Despite the skepticism surrounding hydroxychloroquine as a treatment option for autoimmune disorders, recent studies and evidence suggest that its potential should not be disregarded. The drug has been widely used for decades to treat conditions such as malaria and certain autoimmune diseases like lupus and rheumatoid arthritis. Its favorable safety profile and low cost make it an attractive option for patients who struggle with the high costs and potential side effects of other medications. While some studies have reported inconclusive results regarding the effectiveness of hydroxychloroquine in treating autoimmune disorders, a growing body of evidence indicates its potential to reduce inflammation and modulate the immune response. Ongoing research and clinical trials provide hope for demonstrating the therapeutic benefits of hydroxychloroquine, ultimately shifting the skepticism and highlighting its promising role in the management of autoimmune disorders.